CANC

$36.26

Fund Essentials - as of Oct 31, 2025

Net Assets
$106M
Expense Ratio
0.75%
Dividend Yield (Current)
1.40%
Holdings
53
Inception Date
Aug 15, 2023
Fund Family
Tema Global Limited
Investment Style
••••••••••
Asset Class
••••••••••
Legal Structure
••••••••••
Dividend Frequency
Unspecified

Performance

YTD+0.03%
1 Year+0.42%

Asset Allocation

Stocks: 98.83%
Cash: 1.17%

Price Chart (6M)

View Full Chart →

Top Holdings

View All →
TickerNameWeight
RVMDRevolution Medicines Inc7.31%
LLYEli Lilly & Co.5.94%
BBIOBridgebio Pharma Inc4.34%
RHHBYRoche Holding Ltd Adr4.07%
AZN:LNAstrazeneca Plc3.91%
Top 10 Concentration: 43.68%Report Date: Oct 31, 2025

Dividend Summary

View Details →
Dividend Yield (Current)
1.40%
Frequency
Unspecified
Latest Distribution
$0.02
Dec 10, 2025
12M Distributions
1 payment
Total: $0.02

Peer Comparison

Benchmark
••••••••••
Outperforming by ••••%
Ranked #••• of •,••• funds
This ETF
+••.••%
Peer Avg
+••.••%
Premium Feature
Sign in to unlock peer comparison, category rankings and more
1 Month
+3.38%
YTD
+41.60%
1 Year
+41.60%
3 Year
N/A

Top 10 Holdings (43.7% of portfolio)

#TickerNameSectorWeight
1RVMDRevolution Medicines IncHealth Care7.31%
2LLYEli Lilly & Co.Health Care5.94%
3BBIOBridgebio Pharma IncHealth Care4.34%
4RHHBYRoche Holding Ltd AdrUnknown4.07%
5AZN:LNAstrazeneca PlcUnknown3.91%
6NOVN:SMNovartis AgHealth Care3.82%
7GMABGenmab A/S Sedol 4595739Health Care3.80%
8ACLXACLX Arcellx Inc.Health Care3.58%
9COGTCogent Biosciences IncHealth Care3.46%
10NUVLNuvalent, Inc.Health Care3.45%